Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Education | $6,166 | 5 | 62.6% |
| Food and Beverage | $2,981 | 127 | 30.3% |
| Travel and Lodging | $683.77 | 2 | 6.9% |
| Consulting Fee | $20.23 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Intuitive Surgical, Inc. | $6,805 | 5 | $0 (2019) |
| ABBVIE INC. | $1,174 | 45 | $0 (2024) |
| Astellas Pharma US Inc | $580.64 | 29 | $0 (2024) |
| Myovant Sciences Inc. | $198.23 | 5 | $0 (2022) |
| Teleflex LLC | $189.96 | 8 | $0 (2022) |
| Olympus America Inc. | $148.30 | 4 | $0 (2024) |
| Boston Scientific Corporation | $127.27 | 4 | $0 (2024) |
| Janssen Biotech, Inc. | $89.42 | 4 | $0 (2024) |
| Axonics, Inc. | $71.59 | 4 | $0 (2024) |
| Medtronic, Inc. | $70.07 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $402.04 | 16 | Olympus America Inc. ($84.51) |
| 2023 | $240.33 | 11 | Astellas Pharma US Inc ($59.73) |
| 2022 | $480.20 | 23 | ABBVIE INC. ($176.01) |
| 2021 | $787.92 | 32 | AbbVie Inc. ($229.91) |
| 2020 | $107.79 | 4 | AbbVie Inc. ($81.16) |
| 2019 | $7,081 | 18 | Intuitive Surgical, Inc. ($6,805) |
| 2018 | $343.26 | 13 | AbbVie, Inc. ($258.25) |
| 2017 | $408.27 | 18 | AbbVie, Inc. ($221.99) |
All Payment Transactions
135 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/21/2024 | Boston Scientific Corporation | Rezum Generator (Device) | Food and Beverage | In-kind items and services | $39.66 | General |
| Category: rezum_URO | ||||||
| 10/22/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $20.46 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 10/10/2024 | Tolmar, Inc. | ELIGARD (Drug) | Food and Beverage | Cash or cash equivalent | $21.40 | General |
| Category: ONCOLOGY | ||||||
| 09/27/2024 | Ambu Inc. | — | Food and Beverage | Cash or cash equivalent | $3.07 | General |
| 09/13/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $27.33 | General |
| Category: Oncology | ||||||
| 08/28/2024 | Boston Scientific Corporation | Rezum Generator (Device) | Food and Beverage | In-kind items and services | $37.98 | General |
| Category: rezum_URO | ||||||
| 08/01/2024 | Axonics, Inc. | Axonics (Device) | Food and Beverage | In-kind items and services | $23.12 | General |
| Category: Urology | ||||||
| 07/25/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: HORMONE THERAPY | ||||||
| 06/28/2024 | Tolmar, Inc. | JATENZO (Drug) | Food and Beverage | Cash or cash equivalent | $19.28 | General |
| Category: HORMONE REPLACEMENT | ||||||
| 05/09/2024 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: Oncology | ||||||
| 03/29/2024 | Olympus America Inc. | SOLTIVE (Device) | Food and Beverage | In-kind items and services | $49.40 | General |
| Category: Urology Gynecology | ||||||
| 03/27/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $30.73 | General |
| Category: ENDOCRINOLOGY | ||||||
| 03/14/2024 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $21.37 | General |
| Category: Urology | ||||||
| 02/22/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $21.93 | General |
| Category: Oncology | ||||||
| 01/18/2024 | Olympus America Inc. | SOLTIVE (Device) | Food and Beverage | In-kind items and services | $35.11 | General |
| Category: Urology Gynecology | ||||||
| 01/18/2024 | AngioDynamics, Inc. | NANOKNIFE (Device) | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: OS | ||||||
| 11/17/2023 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: Urology | ||||||
| 11/16/2023 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $19.57 | General |
| Category: Oncology | ||||||
| 10/06/2023 | Olympus America Inc. | Soltive (Device) | Food and Beverage | In-kind items and services | $38.37 | General |
| Category: Urology Gynecology | ||||||
| 07/20/2023 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $20.59 | General |
| Category: Oncology | ||||||
| 07/13/2023 | Tolmar, Inc. | JATENZO (Drug) | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: Endogenous Testosterone Replacement Therapy | ||||||
| 05/25/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $26.17 | General |
| Category: Urology | ||||||
| 04/27/2023 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: Oncology | ||||||
| 03/24/2023 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $24.27 | General |
| Category: Urology | ||||||
| 03/09/2023 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $12.76 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 809 | 1,393 | $518,370 | $69,495 |
| 2022 | 15 | 916 | 1,568 | $572,361 | $76,782 |
| 2021 | 17 | 1,095 | 1,860 | $683,448 | $96,221 |
| 2020 | 12 | 823 | 1,118 | $252,662 | $49,255 |
All Medicare Procedures & Services
68 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 191 | 387 | $100,595 | $25,164 | 25.0% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 15 | 120 | $240,000 | $15,883 | 6.6% |
| 76856 | Complete ultrasound scan of pelvis | Office | 2023 | 67 | 80 | $35,040 | $5,946 | 17.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 56 | 64 | $10,560 | $4,260 | 40.3% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 19 | 20 | $18,160 | $3,754 | 20.7% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 44 | 71 | $7,313 | $3,012 | 41.2% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 35 | 37 | $7,784 | $2,638 | 33.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 25 | 25 | $10,193 | $1,594 | 15.6% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 12 | 14 | $39,424 | $1,421 | 3.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 19 | 25 | $6,500 | $1,305 | 20.1% |
| 81002 | Urinalysis, manual test | Office | 2023 | 184 | 357 | $8,925 | $1,211 | 13.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 12 | 12 | $3,645 | $1,175 | 32.2% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 85 | 113 | $10,057 | $908.00 | 9.0% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 15 | 34 | $6,290 | $777.58 | 12.4% |
| 74420 | Imaging of urinary tract following injection of a contrast agent | Facility | 2023 | 11 | 13 | $7,332 | $260.65 | 3.6% |
| 51741 | Electronic assessment of bladder emptying | Office | 2023 | 19 | 21 | $6,552 | $183.49 | 2.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 206 | 410 | $106,500 | $26,830 | 25.2% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2022 | 14 | 120 | $240,000 | $16,567 | 6.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 71 | 91 | $15,015 | $5,438 | 36.2% |
| 76856 | Complete ultrasound scan of pelvis | Office | 2022 | 62 | 71 | $31,098 | $5,310 | 17.1% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 58 | 114 | $11,742 | $3,748 | 31.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 39 | 39 | $15,876 | $3,129 | 19.7% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 18 | 19 | $17,252 | $3,057 | 17.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 29 | 30 | $9,045 | $2,403 | 26.6% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 26 | 26 | $5,456 | $2,233 | 40.9% |
About Dr. Thomas Malvar, MD
Dr. Thomas Malvar, MD is a Urology healthcare provider based in Chicago, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1528089083.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Malvar, MD has received a total of $9,851 in payments from pharmaceutical and medical device companies, with $402.04 received in 2024. These payments were reported across 135 transactions from 21 companies. The most common payment nature is "Education" ($6,166).
As a Medicare-enrolled provider, Malvar has provided services to 3,643 Medicare beneficiaries, totaling 5,939 services with total Medicare billing of $291,754. Data is available for 4 years (2020–2023), covering 68 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Chicago, IL
- Active Since 07/21/2006
- Last Updated 07/14/2025
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1528089083
Products in Payments
- Da Vinci Surgical System (Device) $6,805
- LUPRON DEPOT (Drug) $528.21
- Lupron (Drug) $356.72
- ORGOVYX (Drug) $214.12
- Myrbetriq (Drug) $191.51
- UroLift System (Device) $189.96
- Lupron Depot (Drug) $144.32
- Androgel (Drug) $123.52
- XTANDI (Drug) $99.84
- ERLEADA (Drug) $89.42
- GEMTESA (Drug) $86.48
- SOLTIVE (Device) $84.51
- MYRBETRIQ (Drug) $79.10
- Rezum Generator (Device) $77.64
- INTERSTIM (Device) $70.07
- Axonics r-SNM System (Device) $48.47
- NOCDURNA (Drug) $47.50
- Soltive (Device) $38.37
- UroLift (Device) $37.73
- JATENZO (Drug) $32.42
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Chicago
Gary Steinberg, M D, M D
Urology — Payments: $586,688
Simone Crivellaro, Md, MD
Urology — Payments: $459,193
Dr. Ashley Ross
Urology — Payments: $382,611
Brian Helfand, M.d./Ph.d, M.D./PH.D
Urology — Payments: $380,392
Amy Krambeck, M.d, M.D
Urology — Payments: $350,930
Dr. Kevin Zorn, M.d, M.D
Urology — Payments: $302,808